James Luther is a Nephrology physician affiliated with Vanderbilt University. OpenAlex indexes 155 publications with 5,034 citations (h-index 40); ClinicalTrials.gov lists 6 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Soluble Epoxide Hydrolase Inhibition and Insulin Resistance
Sponsor: Vanderbilt University Medical Center
- Cardiovascular Effects of GLP-1 Receptor Activation
Sponsor: Vanderbilt University Medical Center
- Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
Sponsor: Vanderbilt University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
5 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
4 NIH research awards on record, funded 2008–2022 per NIH RePORTER. The latest:
- Islet Cell and ST2 Axis Dysregulation in Post-Transplant Diabetes Mellitus
Vanderbilt University Medical Center
FY2022$395,000R01HL141943 - Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity
Vanderbilt University Medical Center
FY2021$467,438R01DK117875 - Variation in Soluble Epoxide Hydrolase Activity and Human Insulin Sensitivity
Vanderbilt University Medical Center
FY2020$467,438R01DK117875
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension
New England Journal of Medicine
2025 - The role of mineralocorticoid receptor activation in kidney inflammation and fibrosis
Kidney International Supplements
2022
Similar KOLs
Other experts from the same institution or the same specialty.
William Schaffner, MD
Vanderbilt University
Keith Obstein, MD, MPH
Vanderbilt University
Andrew Jallouk, MD, PhD
Vanderbilt University
Salim Yusuf
Vanderbilt University
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”